aTyr Pharma | LIFE - Sales Revenues


aTyr Pharma reported $190K in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Ardelyx USD 110.33M 12.67M Sep/2025
aTyr Pharma USD 190K 2.03M Sep/2025
Biogen USD 2.28B 250M Dec/2025
Bristol-Myers Squibb USD 12.5B 300M Dec/2025
Cipla INR 75.18B 710M Dec/2025
Clal Biotechnology ILS 3.41M 2M Dec/2022
Compugen USD 1.89M 631K Sep/2025
CSL USD 3.54B 4.68B Jun/2025
Galapagos EUR 65.3M 4.87M Sep/2025
GlaxoSmithKline GBP 8.62B 73M Dec/2025
Grifols EUR 2.18B 37.55M Sep/2025
Novartis USD 13.91B 144M Sep/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
United Therapeutics USD 799.5M 900K Sep/2025